R&D | November 21, 2025
Lilly expands biotech footprint with new Gateway Labs in Philadelphia
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
The partnership aims to develop novel, selective small molecules targeting TDP-43 pathology
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Subscribe To Our Newsletter & Stay Updated
